PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Successful conclusion to ElringKlinger's 2025 financial year: foundation laid for further transformation ElringKlinger AG concludes successful 2025 financial year with promising results and lays foundation for future transformation. CEO highlights increased revenue in E-Mobility business Revenue Growth Transformation ElringKlinger AG 2025 Financial Year E-Mobility Business
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026 Hong Kong Science and Technology Parks Corporation (HKSTP) and Hong Kong Trade Development Council (HKTDC) showcase 21 tech companies at MWC 2026 & 4YFN 2026 in Spain, highlighting Hong Kong's innovation and technology capabilities to a global audience HKSTP HKTDC MWC 2026 4YFN 2026 Hong Kong Tech Companies
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago LR Health & Beauty SE publishes Q4 2025 report and advances financial and strategic initiatives LR Health & Beauty SE publishes Q4 2025 financial report with sales of EUR 277.1 million, focuses on strategic growth initiatives and new product launch in 2026 Financial Report Strategic Initiatives Product Launch LR Health & Beauty SE Q4 2025
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago SFC Energy AG presents preliminary Group figures for 2025 – Q4 marks return to growth trajectory – Accelerated shift towards defense and public security lays foundation for profitable growth in 2026 SFC Energy AG presents preliminary Group figures for 2025 with Q4 showing growth, focusing on defense and public security for profitable 2026. Sales stable at EUR 143.3 million, leadership in hybrid energy systems Preliminary Results SFC Energy AG Growth Trajectory Defense Public Security
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Weak demand in financial year 2025 reflected in R. STAHL’s figures R. STAHL's 2025 financial year results show weak demand with sales down 9.1% to €313.0 million. EBITDA remains stable at €34.4 million due to positive one-time items EBITDA Financial Year Sales Decline R. STAHL 2025 Results
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Technip Energies remporte un contrat significatif pour le projet de gaz naturel liquéfié flottant Coral Norte au Mozambique Technip Energies remporte un contrat significatif pour le projet FLNG Coral Norte au Mozambique, renforçant ainsi son expertise dans le domaine du GNL. Détails sur l'avancement du projet et les bénéfices prévus GNL Technip Energies Mozambique FLNG Coral Norte Contrat Significatif
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Technip Energies awarded a significant contract for the Coral Norte floating LNG project in Mozambique Technip Energies secures major Coral Norte FLNG project contract in Mozambique, strengthening partnership with Eni and Area 4 partners Partnership Technip Energies Mozambique Coral Norte FLNG Project
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting Nicox announces positive NCX 470 Phase 3 data on intraocular pressure lowering efficacy at 2026 American Glaucoma Society Annual Meeting Nicox NCX 470 Phase 3 Data Intraocular Pressure Glaucoma Society
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 15 days ago Nicox présente des données de Phase 3 positives confirmant le profil thérapeutique de NCX 470 lors du congrès annuel 2026 de l’American Glaucoma Society (AGS) Nicox présente des données de Phase 3 positives pour NCX 470 au congrès annuel 2026 de l'AGS, démontrant une réduction significative de la pression intraoculaire Phase 3 Nicox NCX 470 Pression Intraoculaire Congrès AGS
PRESS RELEASE published on 02/24/2026 at 07:26, 6 months 15 days ago Preliminary figures for 2025: INDUS defies difficult market environment INDUS Holding AG reports resilient performance in 2025 with revenue of EUR 1.74 billion and acquisitions strengthening international presence. Financial statements and guidance for 2026 to be released on March 24, 2026 Financial Statements Revenue Acquisitions INDUS Holding AG 2026 Guidance
Published on 09/11/2026 at 21:25, 13 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 4 hours 38 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 4 hours 38 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 6 hours 13 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 6 hours 38 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 19:44, 1 hour 53 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 3 hours 22 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 3 hours 38 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 14 hours 38 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 14 hours 38 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 14 hours 38 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 14 hours 38 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 2 hours ago Availability of the 2026 Interim Financial Report